Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
MIEBO (PERFLUOROHEXYLOCTANE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
MIEBO
NDA
Get alerts
PERFLUOROHEXYLOCTANE | N216675 | BAUSCH AND LOMB INC
1 strength
6 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Price Trends
Medicare D
DMF
Approvals
Label
Products
Patent Timeline
6 unique patents, 1 exclusivity by expiration date
Active (6)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
Today
10058615
Sep. 12, 2033
10369117
Sep. 12, 2033
10449164
Sep. 12, 2033
10507132
Jun. 21, 2037
10576154
Oct. 1, 2035
11357738
Sep. 29, 2036
NCE
May. 18, 2028
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 1.338GM/ML
RLD
6 patents
1 exclusivity
▴
SOLUTION/DROPS;OPHTHALMIC | Approved: May 18, 2023
Patents (6)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
10058615
Sep 12, 2033
—
—
—
U-1900
TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
—
10369117
Sep 12, 2033
—
—
—
U-1900
TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
—
10449164
Sep 12, 2033
—
—
—
U-1900
TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
—
10507132
Jun 21, 2037
—
—
—
U-1900
TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
—
10576154
Oct 1, 2035
—
—
—
U-1900
TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED)
—
11357738
Sep 29, 2036
—
—
Yes
—
—
Exclusivities (1)
Code
Date
Status
NCE
May 18, 2028
Active